FDA Approves Migraine Drug that Lowers Number of Migraine Days Per Month

Like
Like Love Haha Wow Sad Angry

FDA Approves Drug that Lowers Number of Migraine Days Per Month The U.S. Food and Drug Administration has now a drug called erenumab-aooe and marketed as Aimovig, for the preventive treatment of migraine in adults. The self-injection drug, Aimovig, is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity […]

The post FDA Approves Migraine Drug that Lowers Number of Migraine Days Per Month appeared first on BioTecNika .Read more at www.biotecnika.org/2018/05/fda-approves-drug-that-lowers-number-of-migraine-days-per-month/

Like
Like Love Haha Wow Sad Angry

Related posts